Logotype for ICU Medical Inc

ICU Medical (ICUI) Q4 2016 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for ICU Medical Inc

Q4 2016 earnings summary

6 Nov, 2026

Executive summary

  • FY16 delivered record revenue, cash flow and earnings; the February 2017 Hospira Infusion Systems (HIS) acquisition creates a full-line infusion business and addresses dependence on a major OEM customer.

  • Near-term results may be less predictable during the HIS carve-out and integration; short-term outperformance is not expected, with longer-term value tied to operational improvements and broader distribution.

Financial highlights

  • FY16 revenue was $379.4M vs. $341.7M in FY15; operating income was $82.9M vs. $68.6M; net income was $63.1M vs. $45.0M.

  • Diluted EPS was $3.66 vs. $2.73; operating cash flow was $89.9M vs. $64.2M.

  • Gross margin was 53.1% vs. 52.9%; FY16 included a $7.6M discrete tax benefit from early adoption of ASU 2016-09.

  • Restructuring and strategic transaction expense was $15.3M, including $14.3M of transaction costs; R&D expense declined to $13.0M from $15.7M.

Outlook and guidance

  • Legacy-business 2017 capital expenditures estimated at $18M-$20M; January 2017 Mexico plant expansion completed, with further investment planned in manufacturing equipment and IT.

  • HIS integration expected to disrupt near-term predictability; carve-out challenges and performance depend on integration, operational improvements and successful execution.

  • Planned workforce reduction is expected to incur $3.8M-$4.2M in charges in H1 2017, primarily severance, with most payments expected by Q3 2017 end.

  • Existing cash and anticipated operating cash flows were expected to fund operations for the next 12 months; post-acquisition cash balance was approximately $270M.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from ICU Medical